Related references
Note: Only part of the references are listed.Pharmacokinetics and Pharmacodynamics of Imipenem and Meropenem in Critically Ill Patients Treated With Continuous Venovenous Hemodialysis
David Afshartous et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R. P. Dellinger et al.
INTENSIVE CARE MEDICINE (2013)
Pro: Renal replacement trauma or Paracelsus 2.0
Jan T. Kielstein et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy
S. Vaara et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2012)
Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target
Marilyn N. Martinez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
F. Perry Wilson et al.
CLINICAL NEPHROLOGY (2012)
Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis
A. Mary Vilay et al.
CRITICAL CARE MEDICINE (2011)
Dosing of Antibiotics in Critically Ill Patients Undergoing Renal Replacement Therapy
Jan T. Kielstein et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Lucie Seyler et al.
CRITICAL CARE (2011)
Challenges in Developing Evidence-Based Drug Dosing Guidelines for Adults and Children Receiving Renal Replacement Therapy
B. A. Mueller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data?
A. M. M. Y. Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury
Sergio Vesconi et al.
CRITICAL CARE (2009)
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes
Sean M. Bagshaw et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Higher renal replacement therapy dose delivery influences on drug therapy
BA Mueller et al.
ARTIFICIAL ORGANS (2003)
Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy
N Jumbe et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients
JF Bugge
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2001)
Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock
C Joukhadar et al.
CRITICAL CARE MEDICINE (2001)
Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration
TFT Ververs et al.
CRITICAL CARE MEDICINE (2000)
Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial
C Ronco et al.
LANCET (2000)
Share Paper
